Skip to main content
. 2022 Jan 22;17:299–331. doi: 10.2147/IJN.S347187

Figure 3.

Figure 3

The potential uses of phytochemical/synthetic nanoformulations against multiple neurodegenerative diseases.

Abbreviations: AD, Alzheimer’s disease; ALS, Amyotrophic lateral sclerosis; bFGF, fibroblast growth factor; EPO, erythropoietin; DMF, dimethyl fumarate; EGCG, epigallocatechin 3-gallate; GA, Gallic acid; NPs, nanoparticles; PD, Parkinson’s disease; RA, rosmarinic acid; rtPA, recombinant tissue plasminogen activator.